IL-6 modulates CRC cell proliferation, invasive capacity, and sensitivity to chemotherapeutic agents by participating in the regulation of the JAK2/STAT3 axis [63, 71, 72]. This evidence concerns the gene IL6 and colorectal carcinoma.